Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario

Figure 8

Comparison of the expected value of the cost-per-patient when treating uUTI with fluoroquinolones, sulfonamides, nitrofurantoin, and fosfomycin versus the probability of a uUTI with TMP–SMX-resistant E. coli.